(±)- Trans -2-(3-methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist
- 1 February 1988
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 150 (3), 1213-1220
- https://doi.org/10.1016/0006-291x(88)90758-9
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Structure-activity relationships of kadsurenone analoguesJournal of Medicinal Chemistry, 1987
- PAF-acether specific binding sites: 2. Design of specific antagonistsTrends in Pharmacological Sciences, 1986
- PAF-acether specific binding sites: 1. quantitative SAR study of PAF-acether isosteresTrends in Pharmacological Sciences, 1986
- Platelet activating factor and asthmaInflammation Research, 1986
- ACCUMULATION OF EOSINOPHILS IN RESPONSE TO INTRACUTANEOUS PAF-ACETHER AND ALLERGENS IN MANThe Lancet, 1986
- Schild regressions as indicators of non-equilibrium steady-states and heterogeneous receptor populationsTrends in Pharmacological Sciences, 1985
- Specific binding sites for platelet activating factor in human lung tissuesBiochemical and Biophysical Research Communications, 1985
- Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophilsBiochemical and Biophysical Research Communications, 1984
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- Antihypertensive activity of an alkyl ether analog of phosphatidylcholineBiochemical and Biophysical Research Communications, 1979